What is a peptide COA and what does each section document?
A certificate of analysis (COA) is a structured summary of the analytical tests performed on a specific manufactured lot of a research peptide. It is not a marketing document; it is a traceable quality record tied to a unique batch or lot number. A well-constructed COA identifies the material (sequence name, molecular formula, theoretical monoisotopic and average mass), the batch identifier, manufacture and analysis dates, and the storage conditions under which the sample was held. It then lists each analytical test alongside its result, the method reference, and the acceptance criterion against which the result is judged. Typical fields include appearance, HPLC purity (area percent), identity confirmation by mass spectrometry, net peptide content, water content, counterion (for example trifluoroacetate) content, and where relevant endotoxin or residual solvent results. Reading a COA effectively means treating it as experimental material to be interpreted critically rather than accepted at face value: check that each stated result carries a method and an acceptance limit, and that the batch number on the document matches the batch you physically received. Documentation that omits method references or acceptance criteria is incomplete. As with any technical record, disciplined reading practices — cross-checking figures, noting units, and distinguishing reported values from specification limits — improve the reliability of your own downstream records (Richmond, 1967). The COA should be archived with the batch to preserve traceability for the life of the material.
How is HPLC purity reported and what does area percent mean?
The headline purity figure on most peptide COAs is derived from reversed-phase high-performance liquid chromatography (RP-HPLC), typically with UV detection at 214 nm (peptide bond absorbance) or 220 nm. Purity is expressed as area percent: the integrated area of the main peptide peak divided by the total integrated area of all peaks in the chromatogram, multiplied by 100. A result reported as, for example, 98.2% area at 214 nm means the principal peak accounts for 98.2% of the total detected UV-absorbing material under those conditions. Two points are critical when reading this figure. First, area percent is detector- and wavelength-dependent; species that absorb weakly at the chosen wavelength are under-represented, so the same sample can yield slightly different percentages at 214 nm versus 220 nm. A rigorous COA states the detection wavelength. Second, area percent is a relative measure of chromatographic purity, not an absolute mass assay — it should be read alongside net peptide content, which corrects for water and counterion mass. The COA should also state the gradient, column chemistry (commonly C18), mobile phase (typically water/acetonitrile with an acid modifier), flow rate and run time, because retention behaviour and resolution depend on these parameters. HPLC is the workhorse method for both purity determination and related quantitative assays across biochemistry, and its quantitative output depends directly on reproducible chromatographic conditions (Lambeth et al., 1993). Without the method block, an isolated percentage is difficult to reproduce or compare.
What is peak purity and how is it assessed on a COA?
Peak purity — the query that frequently brings researchers to this topic — refers to whether a single chromatographic peak represents one compound or hides co-eluting impurities beneath it. A high area-percent figure can be misleading if an impurity elutes at the same retention time as the main peptide and is therefore counted as part of the main peak. Peak-purity assessment addresses this. The most common approach uses a photodiode array (PDA/DAD) detector, which records a full UV spectrum across the peak rather than a single wavelength. If the peak is spectrally homogeneous, the UV spectrum at the leading edge, apex and trailing edge should be superimposable; a computed peak-purity index or purity angle within threshold indicates no detectable co-elution. Divergent spectra across the peak flag a possible hidden component. Orthogonal confirmation strengthens the conclusion: analysing the same peak by mass spectrometry (LC-MS) can reveal masses that share retention time but differ in identity, and changing the separation mode or gradient can resolve co-eluting species that a single method masks. One important limitation on any COA is that standard achiral RP-HPLC does not distinguish enantiomers or diastereomers; detecting epimerised residues requires chiral or derivatised methods specifically validated for enantiomeric purity of amino acid building blocks used in synthesis (Szókán et al., 1994). When a COA reports peak purity, note the detector type and the acceptance threshold used, and treat peak purity as complementary to, not a replacement for, mass-spectrometric identity confirmation.
How do identity, net content and counterion data support the purity figure?
A purity percentage alone does not confirm that the material is the intended peptide. Identity is established by mass spectrometry — usually electrospray ionisation (ESI-MS) — where the observed mass is compared with the theoretical monoisotopic or average mass on the COA. A match within the instrument's stated tolerance confirms the molecular weight; tandem MS (MS/MS) can further verify the amino acid sequence via fragment ions. On the COA, look for both the theoretical and observed mass, and check that they agree. Net peptide content is a separate, quantitative value: synthetic peptides are typically isolated as salts and retain bound water, so the actual peptide fraction of a weighed powder is less than 100%. Net content, often determined by amino acid analysis or nitrogen assay, tells you how much peptide is present per unit mass — essential for accurate concentration calculations in your records. Counterion content, most often trifluoroacetate (TFA) from purification, is reported because residual counterion contributes to the powder mass and can interfere with some assays; a TFA figure alongside a counterion-exchange note indicates the manufacturer has characterised this. Water content is commonly measured by Karl Fischer titration. Reading these fields together prevents a common misinterpretation: a 99% HPLC-pure peptide may still be, say, 80% peptide by net mass once water and counterion are accounted for. The COA is coherent only when the chromatographic purity, mass-spec identity, net content and counterion data are read as an interlocking set rather than in isolation.
How should batch numbers, acceptance criteria and traceability be checked?
Traceability is what turns a COA from a claim into a verifiable record. Every result should be linked to a specific lot, and that lot number must match the label on the physical container. This linkage supports lot-release logic: a batch is released against predefined acceptance criteria (for example, HPLC purity ≥ 98.0% area at 214 nm, mass within tolerance, endotoxin below a stated limit), and the COA documents that each result met its criterion. When reading a COA, distinguish the reported result from the specification: '98.6% (spec ≥ 98.0%)' tells you both the measured value and the bar it cleared. Note the analysis date relative to the manufacture date, and the stated storage conditions, because purity and related-substance profiles can change over time through aggregation, oxidation or hydrolysis — a COA is a snapshot at the time of testing. For bulk or repeat orders, retaining COAs allows batch-to-batch comparison and trend monitoring, which is central to a functioning quality system. Sampling plans matter too: a lot-release result is only representative if the tested aliquot was drawn according to a defined sampling protocol. Approach each COA as evidence to be interpreted deliberately, checking internal consistency and completeness before relying on it (Richmond, 1967). Incomplete documents — missing method references, absent acceptance criteria, or a batch number that does not match the vial — should prompt a request for clarification rather than assumption.
Frequently asked questions
What does a purity of 98% on a peptide COA actually mean?
It usually means the main peptide peak accounts for 98% of the total UV-absorbing peak area in the HPLC chromatogram at the stated wavelength. It is a relative chromatographic measure, not an absolute mass figure, so read it alongside net peptide content, which corrects for water and counterion mass.
Why does a COA list the HPLC detection wavelength?
Area-percent purity depends on how strongly each compound absorbs UV light at the detection wavelength. Peptide bonds absorb strongly near 214 nm, so results at 214 nm may differ slightly from 220 nm. Stating the wavelength makes the purity figure reproducible and comparable between batches and laboratories.
What is peak purity and why does it matter?
Peak purity assesses whether a single chromatographic peak represents one compound or conceals co-eluting impurities. It is typically evaluated with a photodiode array detector by comparing UV spectra across the peak, and confirmed orthogonally by mass spectrometry. It guards against a high area-percent value that hides an unresolved component.
How is peptide identity confirmed on a COA?
Identity is generally confirmed by mass spectrometry, most often electrospray ionisation (ESI-MS), by comparing the observed molecular mass with the theoretical mass. Tandem MS can further verify the amino acid sequence. A valid COA shows both theoretical and observed masses agreeing within the method's stated tolerance.
Why does net peptide content differ from HPLC purity?
HPLC purity measures chromatographic composition, while net peptide content measures the actual peptide fraction of the powder by mass. Synthetic peptides carry bound water and counterions such as trifluoroacetate, so a chromatographically pure material can still be well under 100% peptide by weight.
References
- DOI:10.1006/abio.1993.1102 — The Direct Assay of Kinases and Acyl-CoA Synthetases by HPLC: Application to Nucleoside Diphosphate Kinase and Succinyl-CoA Synthetase — Analytical Biochemistry — 1993
- DOI:10.1080/10826079408013498 — HPLC Determination of Enantiomeric Purity of Protected Amino Acid Derivatives Used in Peptide Synthesis — Journal of Liquid Chromatography — 1994
- DOI:10.1002/asi.5090180408 — Suggestions on how to read experimental material in information science — American Documentation — 1967
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
